VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here: IndiaNotes >> Author's Corner >> Businesswire India Press Releases

Businesswire India Press Releases

More Than 7000 Participants of Airtel Delhi Half Marathon Recovered at Volini Recovery Zone

25-11-2014 1:18PM | Source : VOLINI
 
 
For participants of Airtel Delhi Half Marathon, the finish line also meant heading towards Volini “Recovery Zone”. The 6,750 sq ft “Recovery Zone” at the finish line, had professional therapists and sports injury counselors tending to the tired muscles.
 
With masseurs, foam rollers, beds, lounge etc., the “Recovery Zone” was supervised by India’s best known sports scientist Shayamal Vallabhjee. The Recovery Zone facilitated instant pain relief and tending to tired muscles. Talking about the Recovery Zone, Shayamal Vallabhjee, said, “Marathon is a strenuous sport. While running, one is exerting every muscle of the body. Over a period of time, the muscles tend to swell leading to pain. At the Recovery Zone, we helped the participants relax & nursed swollen muscles to get rid of the pain. It’s great to have Volini as the Official Recovery Partner of Airtel Delhi Half Marathon”
 

Brand Ambassador Paula Radcliffe also visited the Recovery Zone to talk about the importance of recovery post marathon. “The awareness towards recovery is very important among the runners. It is as important as training yourself for the run and maintenance of the body for your next event.” Speaking about the “Recovery Zone”, Subodh Marwah, Vice President & Head – Consumer Healthcare, Ranbaxy, said, “Recovery Zone is all about our commitment to provide instant relief and recovery from pain. We are committed to provide pain relief and create recovery zones to all marathon enthusiasts in the forthcoming marathons across India. We want the runners and all fitness enthusiasts to follow their passion without worrying about the pain, as Volini is there to take care of it”
 
Volini by Ranbaxy is a modern day pain reliever scientifically formulated for effective pain relief. It is available in two forms – gel & spray. It can be used for joint, back, neck & shoulder pains, sprains and strains. Committed towards providing instant and long lasting relief, the brand enables people to maximize life, performance and success wherever they are and whenever they need it.
 
Over the years, India’s most respected brands have partnered Procam International’s running events for the transformational role they play in bringing individuals, organizations and institutions together towards the healthy lifestyle. In line with Procam International’s efforts to bring some of the world’s most accomplished sports people to India to raise the profile of distance running as a sport, Paula Radcliffe, English long-distance runner and the current women’s world record holder in the marathon will be the ‘Official Event Ambassador’ of Airtel Delhi Half Marathon 2014.
 
About Volini

Ranbaxy’s Volini is a modern day pain reliever scientifically formulated for effective pain relief. It is the No. 1 doctor recommended and used pain reliever that is available in two formats – Gel & Spray. It can be used for Joint, Back, Neck & Shoulder pains, sprains & strains. Since its switch from Rx to OTC, the brand has grown leaps and bounds, and today is one of India’s biggest pain relieving brands. Committed towards providing instant and long lasting relief, the brand enables people to maximize life, performance and success wherever they are and whenever they need it.

About Ranbaxy

Ranbaxy Laboratories Limited is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals, in developed and emerging markets many of which incorporate proprietary Novel Drug Delivery Systems (NDDS) and technologies, developed at its own labs. The company has further strengthened its focus on generics research and is increasingly working on more complex and specialty areas. Ranbaxy serves its customers in over 150 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 43 countries and manufacturing operations in 8 countries. Ranbaxy is a member of the Daiichi Sankyo Group. Through strategic in-licensing opportunities and its hybrid business model with Daiichi Sankyo, a leading global pharma innovator headquartered in Tokyo, Japan, Ranbaxy is introducing many innovator products in markets around the world, where it has a strong presence. This is in line with the company’s commitment to increase penetration and improve access to medicines, across the globe. For more information, please visit www.ranbaxy.com.

Photo Caption: Left to right- Shayamal Valabhjee- sports scientist, Subodh Marwah- VP &...
 

Lintas PR, Gunjan Kar, +91-9818792486

[email protected]
 

Intraday Tips

What are technical calls?
* SEBI certified analyst


View Stock Advice by: